Total investments received (USD): 144m
Round value (USD): 92m
Company: Pulmocide
Industry:
Health services
Pharma




Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain